Keywords: BCR، عود بیوشیمیایی; treatment outcome; prostatectomy; prostatic neoplasms; robotics; mortalityAJCC, American Joint Committee on Cancer; BCR, biochemical recurrence; CCI, Charlson comorbidity index; LOS, length of stay; NCDB, National Cancer Data Base; ORP, open radical prost
مقالات ISI BCR، عود بیوشیمیایی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; aged; aged, 80 and over; outcome assessment, (health care)ADT, androgen deprivation therapy; ASA®, American Society of Anesthesiologists®; BCR, biochemical recurrence; LE, life expectancy; PCa, prostate cancer; PSA, pro
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; neoplasm recurrence, local; magnetic resonance imaging; diagnostic imaging; prognosisAPC, anterior prostate cancer; BCR, biochemical recurrence; DRE, digital rectal examination; ECE, extracapsular extension; LNI, lymph node involvemen
Keywords: BCR، عود بیوشیمیایی; biopsy; prostatic neoplasms; prostatectomy; recurrence; neoplasm gradingADT, androgen deprivation therapy; BCR, biochemical recurrence; G4%, percent Gleason pattern 4 involvement; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; erectile dysfunctionADT, androgen deprivation therapy; BCR, biochemical recurrence; ED, erectile dysfunction; EPE, extraprostatic extension; IIEF-6, International Index of Erectile Function; MRI, magnetic resonance imag
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostate-specific antigen; watchful waiting; risk; outcome assessment (health care)AS, active surveillance; BCR, biochemical recurrence; BMI, body mass index; GS, Gleason score; HP, high PSA; IP, intermediate PSA; LP, low PSA; PCa, pr
Keywords: BCR، عود بیوشیمیایی; prostate; neoplasm recurrence; local; prostate-specific antigen; radiotherapy; treatment failureADT, androgen deprivation therapy; BCR, biochemical recurrence; BT, brachytherapy; EBRT, external beam radiation therapy; PRB, post-radiation biopsy; PSA, pros
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; testosterone; hormone replacement therapy; radiotherapyADT, androgen deprivation therapy; BCR, biochemical recurrence; CaP, prostate cancer; EBRT, external beam RT; FT, free T; Gl, Gleason score; PIN, prostatic intraepi
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; lymph node excision; salvage therapy; prostate-specific antigenADT, androgen deprivation therapy; BCR, biochemical recurrence; BR, biochemical response; CR, clinical recurrence; CSS, cancer specific survival; CT, comput
Keywords: BCR، عود بیوشیمیایی; prostate; neoplasm recurrence; local; prostatectomy; prostate-specific antigen; prognosisADT, androgen deprivation therapy; BCR, biochemical recurrence; LD, low detectable; NCCN®, National Comprehensive Cancer Network®; ORP, open retropubic RP; PSA, prost
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; testosterone; risk assessment; prostate-specific antigen; neoplasm recurrence, localADT, androgen deprivation therapy; AS, active surveillance; BCR, biochemical recurrence; CaP, prostate cancer; EBRT, external beam radiation therapy;
Expanded Criteria to Identify Men Eligible for Active Surveillance of Low Risk Prostate Cancer at Johns Hopkins: A Preliminary Analysis
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostatectomy; prostate-specific antigen; riskAS, active surveillance; BCR, biochemical recurrence; PSA, prostate specific antigen; PSAd, PSA density; RP, radical prostatectomy
Testosterone Replacement Therapy in Patients with Prostate Cancer After Radical Prostatectomy
Keywords: BCR، عود بیوشیمیایی; testosterone; hormone replacement therapy; prostatic neoplasms; hypogonadism; prostatectomyADT, androgen deprivation therapy; BCR, biochemical recurrence; CaP, prostate cancer; Hct, hematocrit; Hgb, hemoglobin; PSA, prostate specific antigen; PSAV, PSA ve
Operational Characteristics of 11C-Choline Positron Emission Tomography/Computerized Tomography for Prostate Cancer with Biochemical Recurrence After Initial Treatment
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; recurrence; positron-emission tomography and computed tomography; cholineADT, androgen deprivation therapy; BCR, biochemical recurrence; CT, computerized tomography; MRI, magnetic resonance imaging; NPV, negative predictive value; PET
Incremental Value of Magnetic Resonance Imaging for Clinically High Risk Prostate Cancer in 922 Radical Prostatectomies
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostatectomy; magnetic resonance imaging; prognosisAUC, area under ROC curve; BCR, biochemical recurrence; c-index, concordance index; DW, diffusion-weighted; ECE, extracapsular extension; MR, magnetic resonance; PSA, prost
Risk Stratification of Patients with Extraprostatic Extension and Negative Lymph Nodes at Radical Prostatectomy: Identifying Optimal Candidates for Adjuvant Therapy
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostate-specific antigen; nomograms; salvage therapyADT, androgen deprivation therapy; aRT, adjuvant radiation therapy; BCR, biochemical recurrence; PSA, prostate specific antigen; PSM, positive surgical margin; RP, radical
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prognosis; neoplasm metastasis; transcriptomeAUC, area under ROC curve; BCR, biochemical recurrence; CC, clinical only classifier; ECE, extracapsular extension; GC, genomic classifier; GPSM, Gleason score, preoperative PSA,
Detailed Analysis of Patients with Metastasis to the Prostatic Anterior Fat Pad Lymph Nodes: A Multi-Institutional Study
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; neoplasm metastasis; lymph nodes; riskAA, androgen ablation; BCR, biochemical recurrence; CINJ, Cancer Institute of New Jersey; ePLND, extended PLND; PAFP, prostatic anterior fat pad; PCa, prostate cancer; PLND, pelvic lymph
Natural History of Biochemical Recurrence After Radical Prostatectomy with Adjuvant Radiation Therapy
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; neoplasm recurrence; local; prostate-specific antigen; radiotherapy; adjuvantADT, androgen deprivation therapy; ART, adjuvant radiation therapy; BCR, biochemical recurrence; CSS, cancer specific survival; DT, doubling time;
Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; radiotherapy; brachytherapy; treatment outcome3DCRT, 3-dimensional conformal external beam radiotherapy; ADT, androgen deprivation therapy; BCR, biochemical recurrence; bGS, biopsy Gleason score; c-index, concordance in
The Impact of Positive Surgical Margins on Mortality Following Radical Prostatectomy During the Prostate Specific Antigen Era
Keywords: BCR، عود بیوشیمیایی; prostatic neoplasms; prostatectomy; prostate-specific antigenADT, androgen deprivation therapy; BCR, biochemical recurrence; BMI, body mass index; CSS, cancer specific survival; PSA, prostate specific antigen; RRP, radical retropubic prostatectomy; RT, ra
Pathological Stage T2 Subgroups to Predict Biochemical Recurrence After Prostatectomy
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; neoplasm staging; prostate-specific antigen; prostatectomyAJCC, American Joint Committee for Cancer Staging and End Result Reporting; BCR, biochemical recurrence; PCa, prostate carcinoma; PSA, prostate specific antigen; RP,
Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; mortality; disease progression; outcome assessment (health care)ADT, androgen deprivation therapy; BCR, biochemical recurrence; PCa, prostate cancer; PCSM, PCa specific mortality; PSA, prostate specific antigen; RP, radical
Impact of Positive Apical Surgical Margins on Likelihood of Biochemical Recurrence After Radical Prostatectomy
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostatectomy; neoplasm recurrence; local; pathology; surgicalAM+, solitary apical margin positive; BCR, biochemical recurrence; MM+, multiple margins positive; OM+, solitary nonapical margin positive; PCa, prostate carcinom
Radiation Therapy After Radical Prostatectomy: Impact on Metastasis and Survival
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostatectomy; radiotherapy; prostate-specific antigenADT, androgen deprivation therapy; ART, adjuvant radiation therapy; BCR, biochemical recurrence; PSA, prostate specific antigen; PSADT, PSA doubling time; RRP, radical re
Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
Keywords: BCR، عود بیوشیمیایی; hormones; prostatic neoplasms; prostatectomy; survivalADT, adjuvant deprivation therapy; BCR, biochemical recurrence; CSS, cancer specific survival; HT, hormone therapy; PSA, prostate specific antigen; PSADT, prostate specific antigen doubling time; RP, r
Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; prostate-specific antigen; prostatectomy; riskAHT, adjuvant hormonal therapy; BCR, biochemical recurrence; CSS, cancer specific survival; PSA, prostate specific antigen; RRP, radical retropubic prostatectomy; RT, radiation t
Long-Term Outcome After Radical Prostatectomy for Patients With Lymph Node Positive Prostate Cancer in the Prostate Specific Antigen Era
Keywords: BCR، عود بیوشیمیایی; prostate; prostatic neoplasms; lymph node dissection; prostate-specific antigen; prostatectomyADT, androgen deprivation; AHT, adjuvant hormonal therapy; BCR, biochemical recurrence; CSS, cancer specific survival; ECOG, Eastern Cooperative Oncology Group;